CORI™ Knee Tensioner for Knee Replacement Surgery
Trial Summary
What is the purpose of this trial?
To evaluate the performance of the CORI™ KNEE TENSIONER as an accessory to the CORI™ Surgical System.
Do I need to stop my current medications for the trial?
The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.
Is the CORI Knee Tensioner safe for use in knee replacement surgery?
How does the CORI™ Knee Tensioner treatment differ from other knee replacement treatments?
The CORI™ Knee Tensioner is unique because it uses a tensioning device that respects the natural anatomy and ligament strains of the knee, improving ligament balance during knee replacement surgery. This approach, combined with computer-assisted navigation, enhances surgical accuracy and reduces the need for postoperative manipulation compared to traditional methods.13678
Research Team
Kelli Armstrong
Principal Investigator
Smith & Nephew, Inc.
Eligibility Criteria
This trial is for adults over 18 who need a knee replacement due to conditions like osteoarthritis or rheumatoid arthritis and can follow up for one year. They must understand English, not be morbidly obese (BMI under 40), and have no active infections, severe joint diseases, or mental illness affecting compliance.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative
Pre-operative assessments including collection of baseline data and measurements
Surgical Procedure
Robotic-assisted TKA procedure with the CORI Surgical System and CORI™ KNEE TENSIONER
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- REAL INTELLIGENCE Tensioner
Find a Clinic Near You
Who Is Running the Clinical Trial?
Smith & Nephew, Inc.
Lead Sponsor
Dr. Maria Berkman
Smith & Nephew, Inc.
Chief Medical Officer since 2023
MD from Harvard Medical School
Dr. Deepak Nath
Smith & Nephew, Inc.
Chief Executive Officer since 2022
PhD in Theoretical Mechanics, University of California, Berkeley